Literature DB >> 2605350

Growth kinetics of four human breast carcinomas grown in nude mice.

M Spang-Thomsen1, K Rygaard, L Hansen, A C Halvorsen, L L Vindeløv, N Brünner.   

Abstract

The immune-deficient nude mouse with human tumor xenografts is an appropriate model system for performing detailed growth kinetic examinations. In the present study one estrogen and progesterone receptor-negative (T60) and three receptor-positive (Br-10, MCF-7, T61) human breast cancer xenografts in nude mice were investigated. The proliferative tumor characteristics were examined by growth curves, thymidine labelling technique, and flow cytometric DNA analysis performed on fine-needle aspirations. The results showed that the tumors had growth kinetics comparable to other human tumor types with cell generation times of 42 to 60 hours. The three receptor-positive tumors had slower growth rate, larger tumor volume doubling time, and smaller growth fraction and labelling index than the receptor-negative tumor. However, no single proliferation parameter was sufficient to characterize the growth kinetics of individual tumors or to describe proliferative differences between the tumors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2605350     DOI: 10.1007/bf01810740

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  24 in total

1.  Hormone dependency of a serially transplantable human breast cancer (Br-10) in nude mice.

Authors:  S Hirohashi; Y Shimosato; T Kameya; K Nagai; R Tsunematsu
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

2.  The technique of labelled mitoses: analysis by automatic curve-fitting.

Authors:  G G Steel; S Hanes
Journal:  Cell Tissue Kinet       Date:  1971-01

3.  Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry.

Authors:  B Barlogie; W Göhde; D A Johnston; L Smallwood; J Schumann; B Drewinko; E J Freireich
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

Review 4.  Endocrine therapy of human breast cancer grown in nude mice.

Authors:  N Brünner; C K Osborne; M Spang-Thomsen
Journal:  Breast Cancer Res Treat       Date:  1987-12       Impact factor: 4.872

5.  Ploidy, proliferative activity and estrogen receptor content in human breast cancer.

Authors:  M N Raber; B Barlogie; J Latreille; C Bedrossian; H Fritsche; G Blumenschein
Journal:  Cytometry       Date:  1982-07

6.  Changes of proliferation kinetics after X-irradiation of a human malignant melanoma grown in nude mice.

Authors:  M Spang-Thomsen; L L Vindeløv
Journal:  Eur J Cancer Clin Oncol       Date:  1984-06

7.  Dose-dependent effect of 17 beta-estradiol determined by growth curves and flow cytometric DNA analysis of a human breast carcinoma (T61) grown in nude mice.

Authors:  N Brünner; M Spang-Thomsen; L Vindeløv; A Nielsen; S A Engelholm; B Svenstrup
Journal:  Exp Cell Biol       Date:  1985

8.  Correlation of cell-cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer.

Authors:  R E Moran; M M Black; L Alpert; M J Straus
Journal:  Cancer       Date:  1984-10-15       Impact factor: 6.860

9.  Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice.

Authors:  S M Shafie; F H Grantham
Journal:  J Natl Cancer Inst       Date:  1981-07       Impact factor: 13.506

10.  The proliferative patterns of human breast cancer cells in vivo.

Authors:  J Post; R J Sklarew; J Hoffman
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

View more
  1 in total

1.  Paternal programming of breast cancer risk in daughters in a rat model: opposing effects of animal- and plant-based high-fat diets.

Authors:  Camile Castilho Fontelles; Luiza Nicolosi Guido; Mariana Papaléo Rosim; Fábia de Oliveira Andrade; Lu Jin; Jessica Inchauspe; Vanessa Cardoso Pires; Inar Alves de Castro; Leena Hilakivi-Clarke; Sonia de Assis; Thomas Prates Ong
Journal:  Breast Cancer Res       Date:  2016-07-26       Impact factor: 6.466

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.